AI is reshaping drug development — but who will benefit?

Devex·Apr 8

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Artificial intelligence is reportedly changing the process of drug development. The impact of ai on various aspects of the process, including drug discovery, clinical trials, and imaging for oncology, is being explored. It is unclear how the benefits of this shift will be distributed, with some outlets suggesting it may lead to new business opportunities and others focusing on its potential to improve the development process.

Full coverage

Here’s how AI is reshaping drug discovery

The World Economic Forum·Jan 15

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity

24/7 Wall St.·Jun 30

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

CNBC·Jun 5

Fetching the latest headlines…

AI is reshaping drug development — but who will benefit?

Full coverage

Here’s how AI is reshaping drug discovery

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

How AI Is Reshaping Early Drug Development Through a Landmark Partnership

AI Is Changing Pharma’s Bottom Line Now—But Not Through Splashy Drug Discovery

How is AI reshaping the role of the lab bench in drug discovery?

Where AI is Reshaping Imaging for Oncology Drug Development

AI Could Reshape Clinical Trials—and the Business of Pharma